These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9203694)

  • 21. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the dynamics of oral poliovirus vaccine cessation.
    Thompson KM; Duintjer Tebbens RJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S475-84. PubMed ID: 25316870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Israel in the elimination phase of poliomyelitis--achievements and remaining problems.
    Swartz TA; Handsher R
    Public Health Rev; 1993-1994; 21(1-2):99-106. PubMed ID: 8041893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical efficacy of trivalent oral polio vaccine in The Gambia by season of vaccine administration.
    Deming MS; Linkins RW; Jaiteh KO; Hull HF
    J Infect Dis; 1997 Feb; 175 Suppl 1():S254-7. PubMed ID: 9203725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins.
    Afif H; Sutter RW; Kew OM; Fontaine RE; Pallansch MA; Goyal MK; Cochi SL
    J Infect Dis; 1997 Feb; 175 Suppl 1():S71-5. PubMed ID: 9203695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outbreak of paralytic poliomyelitis in the Chechen Republic in 1995.
    Ivanova OE; Eremeeva TP; Lipskaya GY; Cherkasova EA; Gavrilin EV; Drozdov SG
    Dev Biol (Basel); 2001; 105():231-7. PubMed ID: 11763333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.
    Hovi T; Cantell K; Huovilainen A; Kinnunen E; Kuronen T; Lapinleimu K; Pöyry T; Roivainen M; Salama N; Stenvik M
    Lancet; 1986 Jun; 1(8495):1427-32. PubMed ID: 2872526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
    Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
    PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paralytic poliomyelitis outbreak in Gizan, Saudi Arabia.
    Ramia S; Arif M
    J Trop Pediatr; 1991 Aug; 37(4):202-4. PubMed ID: 1960781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():741-6. PubMed ID: 22992572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies.
    Varughese PV; Carter AO; Acres SE; Furesz J
    Can J Public Health; 1989; 80(5):363-8. PubMed ID: 2804867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of paralytic poliomyelitis, Taiwan.
    Kim-Farley RJ; Rutherford G; Lichfield P; Hsu ST; Orenstein WA; Schonberger LB; Bart KJ; Lui KJ; Lin CC
    Lancet; 1984 Dec; 2(8415):1322-4. PubMed ID: 6150332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polio outbreaks in Namibia, 1993-1995: lessons learned.
    Biellik RJ; Allies T; Woodfill CJ; Lobanov A
    J Infect Dis; 1997 Feb; 175 Suppl 1():S30-6. PubMed ID: 9203689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An outbreak of poliomyelitis in Jordan: clinical and epidemiologic observations.
    Daoud AS; al-Sheyyab M; al-Qudah AK; Khuri-Bulos N; el-Shanti H
    Indian Pediatr; 1997 Jan; 34(1):51-4. PubMed ID: 9251280
    [No Abstract]   [Full Text] [Related]  

  • 40. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018.
    Mbaeyi C; Wadood ZM; Moran T; ; Ather F; Stehling-Ariza T; Nikulin J; Al Safadi M; Iber J; Zomahoun L; Abourshaid N; Pang H; Collins N; Asghar H; Butt OUI; Burns CC; Ehrhardt D; Sharaf M
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(24):690-694. PubMed ID: 29927908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.